AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Steminent Biotherapeutics Inc.

TWD 130 +$71.67 (+122.87%)
TWO · 15 Sep 2026 06:59 UTC
Previous Close
TWD 113.5
Day Range
TWD 108.5TWD 130.5
Year Range
TWD 37.85TWD 136
Market Cap
9.5B
AVG Volume
465.44K
Trailing/Forward PE
-42.9/-
PEG ratio
-0.43
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Taipei ExchangeTW
Free Cash Flow Yield
-40%-30%-20%-10%0%med -12.67%Jun 25Aug 25Nov 25Jan 26Apr 26Jul 26Sep 26
7729.TWO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-5.24%
Sep 26-5.19%
Sep 26-7.77%
Aug 26-7.63%
Aug 26-7.54%
Aug 26-7.52%
Aug 26-7.69%
Jul 26-7.53%
Jul 26-7.66%
Jul 26-8.45%
Jul 26-7.54%
Jul 26-8.07%
Jun 26-7.68%
Jun 26-7.11%
Jun 26-7.56%
Jun 26-7.87%
May 26-8.59%
May 26-8.12%
May 26-8.04%
May 26-7.93%
Apr 26-7.57%
Apr 26-7.74%
Apr 26-7.07%
Apr 26-7.8%
Apr 26-7.75%
Mar 26-8.42%
Mar 26-7.61%
Mar 26-7.49%
Mar 26-8.13%
Feb 26-7.53%
Feb 26-8.52%
Feb 26-8.38%
Jan 26-8.65%
Jan 26-7.57%
Jan 26-7.36%
Jan 26-11.35%
Jan 26-11.33%
Dec 25-11.67%
Dec 25-14.84%
Dec 25-15.88%
Dec 25-15.82%
Nov 25-14.99%
Nov 25-15.8%
Nov 25-15.64%
Nov 25-17.07%
Oct 25-16.32%
Oct 25-14.83%
Oct 25-14.88%
Oct 25-14.92%
Oct 25-14.04%
Sep 25-15.25%
Sep 25-16.85%
Sep 25-15.96%
Sep 25-14.76%
Aug 25-13.79%
Aug 25-13.68%
Aug 25-19.73%
Aug 25-25.23%
Aug 25-25.69%
Jul 25-30.12%
Jul 25-28.56%
Jul 25-26.12%
Jul 25-34.49%
Jun 25-36.12%
Jun 25-34.24%
Jun 25-35.69%
Jun 25-34.89%
May 25-33.05%
May 25-32.01%
May 25-33.36%
May 25-32.17%
May 25-32.52%
Apr 25-31.04%
Apr 25-29.62%
Apr 25-37.08%
Apr 25-32.09%
Price to Sales
10001500200025003000med 1282.01Apr 25May 25Jun 25Jul 25Aug 25Aug 25Sep 25
7729.TWO Price to Sales by quarter
PeriodPrice to Sales
Sep 252569.97
Sep 252326.37
Sep 252455.62
Sep 252655.14
Aug 252842.75
Aug 252865.38
Aug 251986.29
Aug 251553.3
Aug 251525.9
Jul 251301.36
Jul 251372.24
Jul 251500.89
Jul 251136.39
Jun 251085.16
Jun 251144.72
Jun 251098.27
Jun 251123.28
May 251185.82
May 251224.53
May 251175.1
May 251218.58
May 251205.47
Apr 251262.65
Apr 251323.4
Apr 251057.17
Apr 251221.55
Price to Book
05101520med 7.36Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
7729.TWO Price to Book by quarter
PeriodPrice to Book
Sep 2611.64
Sep 2611.74
Sep 267.85
Aug 267.99
Aug 268.09
Aug 268.11
Aug 267.93
Jul 268.1
Jul 267.96
Jul 267.22
Jul 268.09
Jul 267.56
Jun 267.94
Jun 268.58
Jun 268.07
Jun 267.75
May 267.1
May 267.51
May 267.59
May 267.69
Apr 268.06
Apr 267.88
Apr 268.63
Apr 267.82
Apr 267.87
Mar 2616.9
Mar 2618.71
Mar 2618.99
Mar 2617.5
Feb 2618.9
Feb 2616.7
Feb 2616.98
Jan 2616.45
Jan 2618.79
Jan 2619.34
Jan 2612.53
Jan 2612.56
Dec 2512.19
Dec 259.59
Dec 258.96
Dec 258.99
Nov 259.49
Nov 259
Nov 259.1
Nov 258.33
Oct 258.72
Oct 259.6
Oct 259.56
Oct 259.53
Oct 2510.14
Sep 256.82
Sep 256.17
Sep 256.51
Sep 257.04
Aug 257.54
Aug 257.6
Aug 255.27
Aug 254.12
Aug 254.05
Jul 253.45
Jul 253.64
Jul 253.98
Jul 253.01
Jun 252.88
Jun 253.04
Jun 252.91
Jun 252.98
May 253.15
May 253.25
May 253.12
May 253.23
May 253.2
Apr 253.35
Apr 253.51
Apr 252.8
Apr 253.24
Mar 252.82
Mar 253.01
Mar 252.53
Mar 252.6
Feb 252.73
Feb 252.66
Feb 252.58
Feb 252.52
Jan 252.5
Jan 252.49
Jan 252.6
Jan 252.72
Dec 242.75
Dec 242.8
Dec 242.79
Dec 242.86
Nov 242.76
Nov 242.73
Nov 242.7
Nov 242.61
Nov 242.7
Oct 242.8
Oct 242.83
Oct 242.84
Steminent Biotherapeutics Inc.
7729.TWO
Stockpicker

Video analysis: 7729.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.